Polyglutamine tract-binding protein-1 binds to U5-15kD via a continuous 23-residue segment of the C-terminal domain

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1804, Issue 7, 2010, Pages 1500-1507

  Takahashi, Masaki ^a   Mizuguchi, Mineyuki ^a   Shinoda, Hiroyuki ^a   Aizawa, Tomoyasu ^b   Demura, Makoto ^b   Okazawa, Hitoshi ^c   Kawano, Keiichi ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Polyglutamine; PQBP 1; Protein structure; U5 15kD; Unstructured protein

Indexed keywords

BINDING PROTEIN; POLYGLUTAMINE TRACT BINDING PROTEIN 1; SMALL NUCLEAR RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FRAMESHIFT MUTATION; MUTANT; PRIORITY JOURNAL; PROTEIN BINDING; X LINKED MENTAL RETARDATION;

AMINO ACID SEQUENCE; CARRIER PROTEINS; FRAMESHIFT MUTATION; GLUTATHIONE TRANSFERASE; HUMANS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; RIBONUCLEOPROTEIN, U5 SMALL NUCLEAR; RNA POLYMERASE II; SEQUENCE HOMOLOGY, AMINO ACID; SPLICEOSOMES;

EID: 77952319537     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2010.03.007     Document Type: Article

References (40)

1. Chiurazzi P., Schwartz C.E., Gecz J., and Neri G. XLMR genes: update 2007. Eur. J. Hum. Genet. 16 (2008) 422-434
2. Ropers H.H., and Hamel B.C. X-linked mental retardation. Nat. Rev. Genet. 6 (2005) 46-57
3. Kalscheuer V.M., Freude K., Musante L., Jensen L.R., Yntema H.G., Gécz J., Sefiani A., Hoffmann K., Moser B., Haas S., Gurok U., Haesler S., Aranda B., Nshedjan A., Tzschach A., Hartmann N., Roloff T.C., Shoichet S., Hagens O., Tao J., Van Bokhoven H., Turner G., Chelly J., Moraine C., Fryns J.P., Nuber U., Hoeltzenbein M., Scharff C., Scherthan H., Lenzner S., Hamel B.C., Schweiger S., and Ropers H.H. Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation. Nat. Genet. 35 (2003) 313-315
4. Lenski C., Abidi F., Meindl A., Gibson A., Platzer M., Frank Kooy R., Lubs H.A., Stevenson R.E., Ramser J., and Schwartz C.E. Novel truncating mutations in the polyglutamine tract binding protein 1 gene (PQBP1) cause Renpenning syndrome and X-linked mental retardation in another family with microcephaly. Am. J. Hum. Genet. 74 (2004) 777-780
5. Waragai M., Lammers C.H., Takeuchi S., Imafuku I., Udagawa Y., Kanazawa I., Kawabata M., Mouradian M.M., and Okazawa H. PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum. Mol. Genet. 8 (1999) 977-987
6. Okazawa H., Sudol M., and Rich T. PQBP-1 (Np/PQ): a polyglutamine tract-binding and nuclear inclusion-forming protein. Brain Res. Bull. 56 (2001) 273-280
7. Okazawa H., Rich T., Chang A., Lin X., Waragai M., Kajikawa M., Enokido Y., Komuro A., Kato S., Shibata M., Hatanaka H., Mouradian M.M., Sudol M., and Kanazawa I. Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron 34 (2002) 701-713
8. Qi Y., Hoshino M., Wada Y., Marubuchi S., Yoshimura N., Kanazawa I., Shinomiya K., and Okazawa H. PQBP-1 is expressed predominantly in the central nervous system during development. Eur. J. NeuroSci. 22 (2005) 1277-1286
9. Ito H., Yoshimura N., Kurosawa M., Ishii S., Nukina N., and Okazawa H. Knock-down of PQBP1 impairs anxiety-related cognition in mouse. Hum. Mol. Genet. 18 (2009) 4239-4254
10. Waragai M., Junn E., Kajikawa M., Takeuchi S., Kanazawa I., Shibata M., Mouradian M.M., and Okazawa H. PQBP-1/Npw38, a nuclear protein binding to the polyglutamine tract, interacts with U5-15kD/dim1p via the carboxyl-terminal domain. Biochem. Biophys. Res. Commun. 273 (2000) 592-595
11. Zhang Y., Lindblom T., Chang A., Sudol M., Sluder A.E., and Golemis E.A. Evidence that dim1 associates with proteins involved in pre-mRNA splicing, and delineation of residues essential for dim1 interactions with hnRNP F and Npw38/PQBP-1. Gene 257 (2000) 33-43
12. Takahashi M., Mizuguchi M., Shinoda H., Aizawa T., Demura M., Okazawa H., and Kawano K. Polyglutamine tract binding protein-1 is an intrinsically unstructured protein. Biochim. Biophys. Acta 1794 (2009) 936-943
13. Zhang Y.Z., Cheng H., Gould K.L., Golemis E.A., and Roder H. Structure, stability, and function of hDim1 investigated by NMR, circular dichroism, and mutational analysis. Biochemistry 42 (2003) 9609-9618
14. Jin T., Guo F., Wang Y., and Zhang Y.Z. Identification of human dim1 as a peptidase with autocleavage activity. Chem. Biol. Drug Des. 68 (2006) 266-272
15. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
16. Johnson B.A. Using NMR View to visualize and analyze the NMR spectra of macromolecules. Methods Mol. Biol. 278 (2004) 313-352
17. Lo K.W., Naisbitt S., Fan J.S., Sheng M., and Zhang M. The 8-kDa dynein light chain binds to its targets via a conserved (K/R)XTQT motif. J. Biol. Chem. 276 (2001) 14059-14066
18. Reuter K., Nottrott S., Fabrizio P., Lührmann R., and Ficner R. Identification, characterization and crystal structure analysis of the human spliceosomal U5 snRNP-specific 15 kD protein. J. Mol. Biol. 294 (1999) 515-525
19. Zamoon J., Nitu F., Karim C., Thomas D.D., and Veglia G. Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4747-4752
20. Sharma A.K., Zhou G.P., Kupferman J., Surks H.K., Christensen E.N., Chou J.J., Mendelsohn M.E., and Rigby A.C. Probing the interaction between the coiled coil leucine zipper of cGMP-dependent protein kinase Ialpha and the C terminus of the myosin binding subunit of the myosin light chain phosphatase. J. Biol. Chem. 283 (2008) 32860-32869
21. Sette M., Van Tilborg P., Spurio R., Kaptein R., Paci M., Gualerzi C.O., and Boelens R. The structure of the translational initiation factor IF1 from E. coli contains an oligomer-binding motif. EMBO J. 16 (1997) 1436-1443
22. Matsuo H., Walters K.J., Teruya K., Tanaka T., Gassner G.T., Lippard S.J., Kyogoku Y., and Wagner G. Identification by NMR spectroscopy of residues at contact surfaces in large, slowly exchanging macromolecular complexes. J. Am. Chem. Soc. 121 (1999) 9903-9904
23. Dyson H.J., and Wright P.E. Unfolded proteins and protein folding studied by NMR. Chem. Rev. 104 (2004) 3607-3622
24. Wright P.E., and Dyson H.J. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293 (1999) 321-331
25. Dunker A.K., Brown C.J., Lawson J.D., Iakoucheva L.M., and Obradović Z. Intrinsic disorder and protein function. Biochemistry 41 (2002) 6573-6582
26. Tompa P. Intrinsically unstructured proteins. Trends Biochem. Sci. 27 (2002) 527-533
27. Tompa P., Fuxreiter M., Oldfield C.J., Simon I., Dunker A.K., and Uversky V.N. Close encounters of the third kind: disordered domains and the interactions of proteins. Bioessays 31 (2009) 328-335
28. Ward J.J., Sodhi J.S., McGuffin L.J., Buxton B.F., and Jones D.T. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J. Mol. Biol. 337 (2004) 635-645
29. Hazy E., and Tompa P. Limitations of induced folding in molecular recognition by intrinsically disordered proteins. Chemphyschem 10 (2009) 1415-1419
30. Dyson H.J., and Wright P.E. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12 (2002) 54-60
31. Fletcher C.M., McGuire A.M., Gingras A.C., Li H., Matsuo H., Sonenberg N., and Wagner G. 4E binding proteins inhibit the translation factor eIF4E without folded structure. Biochemistry 37 (1998) 9-15
32. Sigalov A.B., Kim W.M., Saline M., and Stern L.J. The intrinsically disordered cytoplasmic domain of the T cell receptor zeta chain binds to the nef protein of simian immunodeficiency virus without a disorder-to-order transition. Biochemistry 47 (2008) 12942-12944
33. Clackson T., and Wells J.A. A hot spot of binding energy in a hormone-receptor interface. Science 267 (1995) 383-386
34. de Vos A.M., Ultsch M., and Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255 (1992) 306-312
35. Nielsen T.K., Liu S., Lührmann R., and Ficner R. Structural basis for the bifunctionality of the U5 snRNP 52K protein (CD2BP2). J. Mol. Biol. 369 (2007) 902-908
36. Laggerbauer B., Liu S., Makarov E., Vornlocher H.P., Makarova O., Ingelfinger D., Achsel T., and Lührmann R. The human U5 snRNP 52K protein (CD2BP2) interacts with U5-102K (hPrp6), a U4/U6.U5 tri-snRNP bridging protein, but dissociates upon tri-snRNP formation. RNA 11 (2005) 598-608
37. Makarova O.V., Makarov E.M., Urlaub H., Will C.L., Gentzel M., Wilm M., and Lührmann R. A subset of human 35S U5 proteins, including Prp19, function prior to catalytic step 1 of splicing. EMBO J. 23 (2004) 2381-2391
38. Simeoni F., and Divita G. The Dim protein family: from structure to splicing. Cell. Mol. Life Sci. 64 (2007) 2079-2089
39. Berry L.D., and Gould K.L. Fission yeast dim1(+) encodes a functionally conserved polypeptide essential for mitosis. J. Cell Biol. 137 (1997) 1337-1354
40. Simeoni F., Arvai A., Bello P., Gondeau C., Hopfner K.P., Neyroz P., Heitz F., Tainer J., and Divita G. Biochemical characterization and crystal structure of a Dim1 family associated protein: Dim2. Biochemistry 44 (2005) 11997-12008